BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Business

  Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

  Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.

  May 9, 2024

   · 

  8 min read
• Business

  eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

  eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulator inhibitors for the treatment of cancer, reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.

  May 9, 2024

   · 

  12 min read
• Genetown

  Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results

  Dianthus Therapeutics, Inc. reported financial results for the first quarter ending March 31, 2024, and provided an update on recent business achievements.

  May 9, 2024

   · 

  10 min read
• Business

  Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates

  Gritstone bio, Inc., a clinical-stage biotechnology company working to develop the world’s most potent vaccines, reported financial results for the first quarter ended March 31, 2024 and provided recent corporate and clinical updates.

  May 9, 2024

   · 

  12 min read
• Biotech Bay

  Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference 2024

  Amgen will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:20 a.m. PT on Tuesday, May 14, 2024.

  May 9, 2024

   · 

  2 min read
• Business

  Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results

  Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced financial results for the quarter ended March 31, 2024.

  May 9, 2024

   · 

  10 min read
• Business

  Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights

  Oncolytics Biotech® Inc., a leading clinical-stage company specializing in immunotherapy for oncology, announced recent operational highlights and financial results for the first quarter ended March 31, 2024.

  May 9, 2024

   · 

  15 min read
• Pharm Country

  ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated

  ProPhase Labs, Inc., a next-generation biotech, genomics, and diagnostics company, reported its financial and operational results for the three months ended March 31, 2024.

  May 9, 2024

   · 

  24 min read
• Business

  Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress

  Ventyx Biosciences, Inc. announced financial results for the first quarter ended March 31, 2024, and highlighted recent pipeline and business progress.

  May 9, 2024

   · 

  10 min read
• Business

  ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results

  ARS Pharmaceuticals, Inc., a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, reported business updates and financial results for the first quarter of 2024.

  May 9, 2024

   · 

  12 min read